Are citalopram and escitalopram (selective serotonin reuptake inhibitors (SSRIs)) the same?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are Citalopram and Escitalopram the Same?

No, citalopram and escitalopram are not the same medication—escitalopram is the isolated S-enantiomer of citalopram and demonstrates superior efficacy, faster onset of action, and fewer drug interactions than the racemic mixture. 1, 2

Chemical Relationship

  • Citalopram is a racemic mixture containing equal amounts (1:1) of both S-enantiomer (escitalopram) and R-enantiomer (R-citalopram). 1, 3
  • Escitalopram is the pure S-enantiomer extracted from citalopram, containing only the therapeutically active isomer. 1, 4
  • The molecular formula for escitalopram oxalate is C20H21FN2O • C2H2O4 with a molecular weight of 414.40. 1

Why Escitalopram Performs Better

The R-enantiomer present in citalopram actively counteracts the therapeutic effects of the S-enantiomer through an allosteric interaction at the serotonin transporter. 3, 5

Mechanism of R-Enantiomer Interference:

  • R-citalopram binds to an allosteric (secondary) site on the serotonin transporter and decreases escitalopram's binding effectiveness at the primary orthosteric site. 5
  • In microdialysis studies, escitalopram increased extracellular serotonin levels in the frontal cortex and ventral hippocampus, but this effect was prevented by concomitant R-citalopram administration. 5
  • Escitalopram was four times more potent than citalopram in suppressing firing activity of serotonin neurons in the dorsal raphe nucleus. 5

Clinical Efficacy Differences

Pooled analysis of three randomized controlled trials demonstrated that escitalopram separated from placebo after 1 week of treatment, while citalopram required 4-6 weeks to show statistical separation from placebo. 6

Key Clinical Advantages of Escitalopram:

  • Higher response rates: More patients achieved ≥50% improvement in Montgomery-Åsberg Depression Rating Scale (MADRS) scores with escitalopram versus citalopram. 6
  • Faster onset: Escitalopram showed statistically significant improvements in all efficacy measures after 1 week, compared to 4-6 weeks for citalopram. 6
  • Greater magnitude of effect: Escitalopram demonstrated superior efficacy at multiple time points throughout treatment. 6

Drug Interaction Profile

Escitalopram has the lowest propensity for drug-drug interactions among all SSRIs due to minimal effects on CYP450 isoenzymes, while citalopram has moderate interaction potential. 7, 8

  • Citalopram/escitalopram may have the least effect on CYP450 isoenzymes compared with other SSRIs. 7
  • Both medications can interact with drugs that prolong the QT interval, but citalopram carries a specific FDA boxed warning not to exceed 40 mg/day (or 20 mg/day in adults >60 years) due to dose-dependent QT prolongation risk. 7

Practical Prescribing Implications

When choosing between these medications, escitalopram offers approximately twice the potency of citalopram at equivalent S-enantiomer doses, with better tolerability and faster therapeutic response. 2, 4

Dosing Equivalence:

  • Escitalopram 10 mg contains the same amount of active S-enantiomer as citalopram 20 mg. 6
  • Escitalopram 20 mg is equivalent to citalopram 40 mg in S-enantiomer content. 6

Common Pitfall to Avoid:

  • Do not assume these medications are interchangeable at the same milligram dose—escitalopram requires half the dose of citalopram to deliver equivalent amounts of the active S-enantiomer. 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.